Cargando…

Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease

Parkinson's disease (PD) is manifested by progressive motor, autonomic, and cognitive disturbances. Dopamine (DA) synthesizing neurons in the substantia nigra (SN) degenerate, causing a decline in DA level in the striatum that leads to the characteristic movement disorders. A disease-modifying...

Descripción completa

Detalles Bibliográficos
Autores principales: Palasz, Ewelina, Niewiadomski, Wiktor, Gasiorowska, Anna, Wysocka, Adrianna, Stepniewska, Anna, Niewiadomska, Grazyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838750/
https://www.ncbi.nlm.nih.gov/pubmed/31736859
http://dx.doi.org/10.3389/fneur.2019.01143
_version_ 1783467277916569600
author Palasz, Ewelina
Niewiadomski, Wiktor
Gasiorowska, Anna
Wysocka, Adrianna
Stepniewska, Anna
Niewiadomska, Grazyna
author_facet Palasz, Ewelina
Niewiadomski, Wiktor
Gasiorowska, Anna
Wysocka, Adrianna
Stepniewska, Anna
Niewiadomska, Grazyna
author_sort Palasz, Ewelina
collection PubMed
description Parkinson's disease (PD) is manifested by progressive motor, autonomic, and cognitive disturbances. Dopamine (DA) synthesizing neurons in the substantia nigra (SN) degenerate, causing a decline in DA level in the striatum that leads to the characteristic movement disorders. A disease-modifying therapy to arrest PD progression remains unattainable with current pharmacotherapies, most of which cause severe side effects and lose their efficacy with time. For this reason, there is a need to seek new therapies supporting the pharmacological treatment of PD. Motor therapy is recommended for pharmacologically treated PD patients as it alleviates the symptoms. Molecular mechanisms behind the beneficial effects of motor therapy are unknown, nor is it known whether such therapy may be neuroprotective in PD patients. Due to obvious limitations, human studies are unlikely to answer these questions; therefore, the use of animal models of PD seems indispensable. Motor therapy in animal models of PD characterized by the loss of dopaminergic neurons has neuroprotective and neuroregenerative effects, and the completeness of neuronal protection may depend on (i) degree of neuronal loss, (ii) duration and intensity of exercise, and (iii) time elapsed between insult and commencing of training. As the physical activity is neuroprotective for dopaminergic neurons, the question arises what is the mechanism of this protective action. A current hypothesis assumes a central role of neurotrophic factors in the neuroprotection of dopaminergic neurons, even though it is still not clear whether increased DA level in the nigrostriatal axis results from neurogenesis of dopaminergic neurons in the SN, recovery of the phenotype of dopaminergic neurons, increased sprouting of the residual dopaminergic axons in the striatum, or generation of local striatal neurons from inhibitory interneurons. In the present review, we discuss studies describing the influence of physical exercise on the PD-like changes manifested in animal models of the disease and focus our interest on the current state of knowledge on the mechanism of neuroprotection induced by physical activity as a supportive therapy in PD.
format Online
Article
Text
id pubmed-6838750
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68387502019-11-15 Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease Palasz, Ewelina Niewiadomski, Wiktor Gasiorowska, Anna Wysocka, Adrianna Stepniewska, Anna Niewiadomska, Grazyna Front Neurol Neurology Parkinson's disease (PD) is manifested by progressive motor, autonomic, and cognitive disturbances. Dopamine (DA) synthesizing neurons in the substantia nigra (SN) degenerate, causing a decline in DA level in the striatum that leads to the characteristic movement disorders. A disease-modifying therapy to arrest PD progression remains unattainable with current pharmacotherapies, most of which cause severe side effects and lose their efficacy with time. For this reason, there is a need to seek new therapies supporting the pharmacological treatment of PD. Motor therapy is recommended for pharmacologically treated PD patients as it alleviates the symptoms. Molecular mechanisms behind the beneficial effects of motor therapy are unknown, nor is it known whether such therapy may be neuroprotective in PD patients. Due to obvious limitations, human studies are unlikely to answer these questions; therefore, the use of animal models of PD seems indispensable. Motor therapy in animal models of PD characterized by the loss of dopaminergic neurons has neuroprotective and neuroregenerative effects, and the completeness of neuronal protection may depend on (i) degree of neuronal loss, (ii) duration and intensity of exercise, and (iii) time elapsed between insult and commencing of training. As the physical activity is neuroprotective for dopaminergic neurons, the question arises what is the mechanism of this protective action. A current hypothesis assumes a central role of neurotrophic factors in the neuroprotection of dopaminergic neurons, even though it is still not clear whether increased DA level in the nigrostriatal axis results from neurogenesis of dopaminergic neurons in the SN, recovery of the phenotype of dopaminergic neurons, increased sprouting of the residual dopaminergic axons in the striatum, or generation of local striatal neurons from inhibitory interneurons. In the present review, we discuss studies describing the influence of physical exercise on the PD-like changes manifested in animal models of the disease and focus our interest on the current state of knowledge on the mechanism of neuroprotection induced by physical activity as a supportive therapy in PD. Frontiers Media S.A. 2019-11-01 /pmc/articles/PMC6838750/ /pubmed/31736859 http://dx.doi.org/10.3389/fneur.2019.01143 Text en Copyright © 2019 Palasz, Niewiadomski, Gasiorowska, Wysocka, Stepniewska and Niewiadomska. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Palasz, Ewelina
Niewiadomski, Wiktor
Gasiorowska, Anna
Wysocka, Adrianna
Stepniewska, Anna
Niewiadomska, Grazyna
Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease
title Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease
title_full Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease
title_fullStr Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease
title_full_unstemmed Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease
title_short Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease
title_sort exercise-induced neuroprotection and recovery of motor function in animal models of parkinson's disease
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838750/
https://www.ncbi.nlm.nih.gov/pubmed/31736859
http://dx.doi.org/10.3389/fneur.2019.01143
work_keys_str_mv AT palaszewelina exerciseinducedneuroprotectionandrecoveryofmotorfunctioninanimalmodelsofparkinsonsdisease
AT niewiadomskiwiktor exerciseinducedneuroprotectionandrecoveryofmotorfunctioninanimalmodelsofparkinsonsdisease
AT gasiorowskaanna exerciseinducedneuroprotectionandrecoveryofmotorfunctioninanimalmodelsofparkinsonsdisease
AT wysockaadrianna exerciseinducedneuroprotectionandrecoveryofmotorfunctioninanimalmodelsofparkinsonsdisease
AT stepniewskaanna exerciseinducedneuroprotectionandrecoveryofmotorfunctioninanimalmodelsofparkinsonsdisease
AT niewiadomskagrazyna exerciseinducedneuroprotectionandrecoveryofmotorfunctioninanimalmodelsofparkinsonsdisease